Quantlens

QuantLens (BioTrials Clinical Catalyst) — Pre-joined clinical-trials-to-equity bridge: 558,973 trial records (1999–2025) resolved to 48K+ sponsors and 1,515 mapped public tickers, with 168,131 labeled catalyst events carrying 1d/5d/20d forward equity returns and volatility, plus FDA application links, patent cross-references, MeSH/ICD-10 condition mappings and trial-level outcome labels. Micro specialist alt-data publisher operating a small multi-pack catalogue (BioTrials clinical trials, FedEventBench/FedFlow procurement signals, PatentPulse Archive, ConstructAlpha, NeuralFlow AlphaDeck) wit…

Quantlens offers (Alternative, Fundamental, Price, Reference) — 558,973 trial records; 48,000+ sponsor entities; 1,515 mapped tickers; 168,131 labeled catalyst events with forward-return columns; plus separate sponsor and catalyst tables — a multi-table Parquet lake partitioned by year/event date.

Event-driven and long/short biotech strategy construction using trial outcomes as catalysts; backtesting clinical-event alpha across 26 years; pipeline and drug-development success-rate modelling; cross-sectional biotech factor construction; ML feature engineering for healthcare equity models; validating a new clinical-event signal against a labeled historical baseline

The data is with 26 years of history.

Coverage spans US, UK, Europe, China/HK, Japan; Financial Exchanges & Data, Health Care Technology; alternative, fundamental, price, reference; equities, options.

The supplier's own access route is a conversation with the supplier. Request a sample through Brickroad to start.